|
DSTYK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.346300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.396200E-02 |
| Normal-vs-Stage2 |
8.385900E-02 |
| Normal-vs-Stage3 |
7.137400E-03 |
| Normal-vs-Stage4 |
1.460320E-03 |
| Stage1-vs-Stage2 |
7.550600E-01 |
| Stage1-vs-Stage3 |
2.010800E-01 |
| Stage1-vs-Stage4 |
4.382100E-02 |
| Stage2-vs-Stage3 |
5.771600E-01 |
| Stage2-vs-Stage4 |
2.345200E-01 |
| Stage3-vs-Stage4 |
4.116200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.094200E-02 |
| Normal-vs-AfricanAmerican |
8.317800E-01 |
| Normal-vs-Asian |
2.654300E-02 |
| Caucasian-vs-AfricanAmerican |
1.652960E-01 |
| Caucasian-vs-Asian |
8.340000E-01 |
| AfricanAmerican-vs-Asian |
1.355750E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.780300E-03 |
| Normal-vs-Female |
4.433900E-02 |
| Male-vs-Female |
4.335800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.112840E-01 |
| Normal-vs-Age(41-60Yrs) |
4.731600E-02 |
| Normal-vs-Age(61-80Yrs) |
7.022700E-04 |
| Normal-vs-Age(81-100Yrs) |
3.652000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.795400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.868200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.898400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.813700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.115600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.975600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.52028999998999E-05 |
| Classical-VS-Follicular |
3.438400E-02 |
| Classical-VS-Other |
2.229000E-01 |
| Classical-VS-Normal |
2.075000E-01 |
| Tall-VS-Follicular |
3.596200E-02 |
| Tall-VS-Other |
6.443400E-01 |
| Tall-VS-Normal |
4.41569999998226E-06 |
| Follicular-VS-Other |
6.039000E-01 |
| Follicular-VS-Normal |
8.055100E-03 |
| Other-VS-Normal |
6.721600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.964250E-02 |
| Normal-vs-N1 |
9.204300E-04 |
| N0-vs-N1 |
9.433500E-02 |
|
|
